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Brain nitric oxide synthase is a Ca2~/ca1modulin-re~lat~ enzyme which converts L-arginine into NO. Enzymatic activity of this enzyme essentially 
depends on NADPH and is stimulated by tetrahydrobiopterin (H,biopterin). We found that purified NO synthasc contains enzyme-bound H.,biop- 
terin, explaining the enzymatic activity observed in the absence of added cofactor. Together with the finding that H.,biopterin was effective at sub- 
stoichiomctrical concentrations, these results indicate that NO synthase essentially depends on H_,biopterin as a cofactor which is recycled during 
enzymatic NO formation. We found that the purified enzyme also contains FAD, FMN and non-hcme iron in equimolar amounts and exhibits 
striking activities. including a Ca2”/calmodulin-depcndent NADPH oxidase activity, leading to the formation of hydrogen peroxide at suboptimal 
concentrations of L-arginine or H_,biopterin. 
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1. INTRODUCTION 
Nitric oxide represents an intra- and intercellular 
signal molecule with soluble guanylyl cyclase as effector 
enzyme. It is involved in the regulation of vascular tone, 
acts as a messenger molecule in the central nervous 
system and mediates the cytotoxicity of immunological- 
ly activated cells (far review see [l-3]). Until now, at 
least two forms of NO-generating enzymes have been 
described: a Ca’+-regulated enzyme which is con- 
stitutively expressed in endothelial cells [4], lung [5], 
adrenal gland [6], platelets [7], neutrophils [S] and 
brain [9-l 11, and a Ca2+-independent, cytokine- 
inducible enzyme form in macrophages [12-141, Kupf- 
fer cells [15]. hepatocytes [16], endothelial cells [17], 
and smooth muscle cells [18]. 
to enzyme-bound Hsbiopterin and that the cofactor is 
apparently recycled at the expense of NADPH during 
NO synthesis. The purified enzyme is further 
characterized as a non-heme iron-containing flavopro- 
tein which acts as Ca’+/calmodulin-dependent 
NADPH:oxygen oxido-reductase catalyzing the forma- 
tion of hydrogen peroxide instead of L-citrulline and 
NO at low concentrations of L-arginine or Hdbiopterin. 
2. MATERIALS AND METHODS 
2. I . Malerials 
The reaction mechanism of NO formation is not yet 
fully understood. Both types of NO synthases similarly 
convert the guanidino group of L-arginine into NO and 
L-citrulline, essentially depend on NADPH and are 
stimulated by Hdbiopterin [8,10,19,20]. In a first reac- 
tion step, the macrophage nzyme apparently catalyzes 
a monooxygenase-like hydroxylation of L-arginine into 
NO-hydroxy-L-arginine which apparently reacts with 
molecular oxygen to yield L-citrulline and NO [21,22]. 
L-[2,3-‘Hlarginine (spec, act. 40-70 Ci/mmol) was obtained from 
DuPont de Ncmours, Dreieich, Germany and purified by HPLC us- 
in8 100 mM sodium acetate buffer, pH 4.5, as eluant. The ion ex- 
change resin AG SOW-X8 was from Sigma, Dcisenhofcn, Germany; 
2 ’ ,5 ’ -ADP-Sepharosc was from Pharmacia-LKB, Freiburg, Gcr- 
many; and (6R)-5,6,7,8-tctrahydro-L-biopterin was obtained from Dr 
B. Schircks Laboratories, Jona, Switzerland. NADPH was purchased 
from Waldhof, Diisseldorf, Germany. Other reagents, solvents and 
salts were of analytical grade and were obtained from Sigma, 
Dcisenhofen, Germany, or Merck, Darmstadt, Germany. 
2.2. Enzyme preparation 
In the present study we show that the observed 
Hdbiopterin-independent activity of NO synthase is due 
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For the purification of Ca2+ -regulated NO synthasc from porcine 
ccrcbcllum, a method described previously [IO] was scaled-up and 
slightly modified, rcsuhing in a marked incrcasc in enzyme recovery. 
About 3 kg of porcine ccrebclla were homogenized with an Ultra- 
Turrax in 3 vols of a 50 mM triethanolamine/HCl buffer, pH 7.5, 
containing 0.5 mM EDTA (buffer A). After ccnlrifugation (30 min, 
IoCWX)X~,J, solld ammonium sulfare (176 g/l) was added to the 
supcrnntant IO prcclpitatc NO synthasc. The pellets wcrc washed once 
wilh 5 I of buffer A containing 176 g/l of ammonium sulfate ond then 
dissolved in a 20 mM ~ricthanolamlnc/HCI buffer, pH 7.5, comin- 
ing 0,s mM EDTA und IO mM 2.mcrcaptocthnnol so that the conduc- 
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tivity of the suspension was not higher than about 10 mS/cm. After 
centrifugation (40 min. 1OOOOxg,,), the supernatant was mixed with 
25 ml of 2’,5’-ADP-Sepharose which had been pre-equilibrated with 
buffer A containing 10 mM 2-mercaptoeihanol (buffer B). The slurry 
was stirred for 30 min, poured into a column, and the Sepharose was 
washed with 250 ml of buffer Et containing 0.5 M NaCI, followed by 
250 ml of buffer B and 50 ml of buffer B containing 0.5 mM NADPH. 
NO synthase was eluted with 80 ml of buffer B containing 10 mM 
NADPH. and the eluate was immediately concentrated with 
Centricon- microconcentrators (Amicon, Witten, Germany). The 
concentrate was washed 3 times with buffer B to reduce the concentra- 
tion of NADPH, and the enzyme (0.2-0.4 mg/ml) was stored with 
20% (v/v) glycerol at - 70°C. Using this purification procedure, we 
obtained about 2 mg of NO synthase of a purity of greater than 95oib 
as judged from the Coomassie blue-stained gels. 
For some experiments, tOOpI of purified NO syr.thase was further 
chromatographed on a Superose 6 gel filtration column (1 x 30 cm; 
Pharmacia-LKB, Freiburg, Germany) which had been pre- 
equilibrated in a 50 mM triethanolamine/HCl buffer, pH 7.0, con- 
taining 0.5 mM EDTA and 0.5 M NaCl. The enzyme was eluted with 
the same buffer at a flow rate of 0.5 ml/mitt, and active fractions were 
pooled. Protein was determined by the method of Bradford 1231 with 
bovine serum albumin as standard protein. 
2.3. Determination of envyme-bound pteridines 
In lOO,ul of a solution containing 0.4 mg/ml of purified NO syn- 
thase. the reduced forms of pteridines were oxidized with 0.01 M KIJ 
in 5 M HJPOJ or in 0.1 M NaOH for 60 min in the dark. After 
acidification of the basic solution with 5 M HsPOJ and destruction of 
excess iodine by 0.1 M ascorbic acid, samples were applied to strong 
ion exchange solid phase cartridges (Varian, Palo Alto, CA, USA) 
and directly eluted by means of an automated device (AASP, Varian) 
to a 250x4 mm reversed phase column (Lichrosorb RP-18, Merck, 
Darmstadt, Germany) and detected by fluorescence as previously 
described [24]. 
2 -4. Determination of reduced Jhvins 
NO synthase purified from porcine cerebellum was chroma- 
tographed on Superose 6 as described in section 2.2., heated for 5 min 
in a boiling water bath in the dark, and 50 ~1 were subsequently in- 
jected into an HPLC system (Vista 5560, Varian). A reversed phase 
column (Lichrosorb RP-18, Merck) was eluted with 0.01 M potassium 
phosphate buffer, pH 6.0, containing 19% (v/v) methanol at a flow 
rate of 0.8 ml/min with a linear gradient to 57% methanol in 15 min. 
Flavins were detected simultaneously with UV-absorption at 447 nm, 
and fluorescence detection (LS4, Perkin Elmer, Beaconsfield, UK) at 
excitation 450 nm, emission 520 nm. 
2 -5, Enzyme assays 
Routinely, NO synthase activity was determined as formation of 
[‘Hjcitrulline from [‘Hlarginine as previously described (251. For all 
experiments evaluating the stoichiometry of the reaction, 2-mcr- 
captoethanol and NADPH were removed from enzyme preparations 
by gel filtration (see 2.2.). The ratio of NADPH utilized to L- 
citruliinc formed was dctermincd by incubation of the thiol- and 
NADPH-free enzyme (30-60 ng) at 37’C for I h with 0.05-1.0 nmol 
of NADPH in a volume of 0.1 ml in the presence of 100 14cM 
[“Hlargininc (IOOC#Ocpm), 3lM freeCa’*, IOpg/ml calmodulin and 
1OpM HJ bioptcrin, followed by the determination of [‘Hjcitrullinc 
formed. Similarly, the enzyme was incubated with defined, subop- 
timfll amounts of Habiopterin (0.05-I nmol in 0. I ml) at saturating 
(100 PM) concentrations of NADPH. For the dctcrmination of the 
specific NADPH-consuming activity, NO synthase (2 fig) was in- 
cubated in a volume of 0.2 ml in tire presence of IOOrM NADPH and 
3 PM free Ca2’ in the presence nnd abscncc of lOrg/ml calmodulin 
at ambient tempcraturc, and the decrease In absorbance at 340 nm 
wns continuously monitored against blank sampler containing buffer 
instead nf sneymc, For the continuous monitoring of oxypen-uptake 
Willg al oxypcn-sensitive clectrodc(l3rnun, Mclsungcn, Germany), 50 
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/rg of NO synthase were incubated at ambient temperature in 2.5 ml 
volumes with 100&M NADPH and 3pM free Ca” in the presence and 
absence of lO,ug/ml calmodulin. 
3. RESULTS AND DISCUSSION 
In previous studies it was found that the Ca’+- 
regulated brain NO synthase shows activity without 
added Hdbiopterin, and it had been concluded that the 
brain enzyme does not depend on Hdbiopterin 19,261. 
This contrasted to findings with the inducible macro- 
phage NO synthase and, thus, was taken as a feature 
distinguishing two forms of NO synthase in mechanistic 
properties. Recent studies, however, revealed that the 
purified, Ca’+ -regulated enzyme exhibits a basal activi- 
ty which is enhanced in the presence of added 
Hdbiopterin [&lo]. We examined NO synthase purified 
from porcine cerebellum for enzyme-bound pteridines 
by HPLC (Fig. 1) and found that the purified protein 
contains 0.035-0.090 mol of biopterin per mol of 160 
kDa [lo] subunit, with more than 95% present in the 
tetrahydro form. Together with the pronounced 
stimulatory effect of Hdbiopterin on the activity of the 
enzyme [lo], these results clearly suggest that brain NO 
synthase does essentially depend on Hdbiopterin as a 
cofactor. 
NO synthase purified from activated macrophages i
a flavoprotein containing FAD and FMN [27]. Super- 
natants of heat-denaturated purified brain NO synthase 
6 lb 2’0 3b- 
Relention timelnrin) 
Fig. I. HPLC analysis of enzyme-bound ptcridincs in NO synfhasc 
purified from porcine ccrcbellum. In preparations of NO synrhase 
purified from porcine cerebellum, the rcduccd forms of pteridines 
wcrc oxidized at acidic (~rp/~er pnnel) or alkaline (lo~crparte/) condi- 
tions and analyzed by reverse phase HPLC with fluorcsccncc detcc- 
tion as dcscribcd in section 2. Peak 1 corresponds IO biopterin, which 
is formed from dihydro- and tetrehydrobioytcrin by oxidation in acid 
(t//~/jer ~/nnrr) or from dihydrobioptcrin by oxidation in alkaline 
medium (luiv~r parret). Pcsk 2 corresponds to ptcrin, tlrc product of 
tctrahydrobioptcrin oxidation in alkaline media (lowr purref). 
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exhibited fluorescence spectra typical for flavins 
(Fig. 2). The intensity of the fluorescence was not af- 
fected by acidification, indicating that a mixture of 
FAD and FMN was present. Subsequent to separation 
by HPLC, the flavins were quantitatively determined 
using UV and fluorescence detection with authentic 
FAD and FMN as reference compounds. Between 0.6 
and 0.9 mol of each, FAD and FMN, were found per 
mol of 160 kDa subunit of NO synthase, and the flavins 
were present in equimolar amounts (see Fig. 2). Thus, 
whereas one mol of FAD and only 0.5 mol of FMN 
were reported to be present per mol of subunit of the 
purified macrophage nzyme 1271, brain NO synthase 
apparently contains equimolar amounts of the non- 
covalently bound reduced flavins. 
Atomic absorption spectroscopy of 2 enzyme 
preparations howed 0.72 and I .I 1 mol of iron per mol 
of 160 kDa subunit. The purified enzyme lacked the 
typical UV/VIS absorption spectrum of heme (not 
shown), so that brain NO synthase, like other pteridine- 
dependent hydroxylating enzymes 1281, represents a 
non-heme iron protein. For experiments investigating 
the stoichiometry of the reaction, we removed 
2-mercaptoethanol and NADPH from the enzyme 
preparations by gel filtration chromatography on 
Superose 6. Incubations with defined, suboptimal 
amounts of NADPH in the presence of 10 PM H4 
biopterin showed a consumption of 1.52t0.028 nmol 
(mean f SE; n = 12) per nmol of L-citrulline formed. At 
saturating conditions of NADPH, 0.05 nmol of 
Hdbiopterin was sufficient for the formation of 1.3 
400 500 600 
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Fig. 2. HPLC profiles and fluorcsccncc spectra (i~rser) of flavins in 
supcrnarants of heat-denatured brain nitric oxide synthasc. NO syn- 
thase purified from porcine cerebellum was heated for 5 min in a boil- 
ing water bath in the dark to rclcasc non-covalcntly bound flavins, 
and IIIC in:et shows the fluorcsccnce excitation and emission spectra 
of the :upcrnntant. The excitation spectrum (dnshcd line) was 
monitored at an emission wavclcngth of 525 nm, the emission spcc- 
trurn (solid line) was rccordcd a~ an excitation wavclcngth of 450 nm. 
Pluvins wcrc separated by rcvcrscd phnsc HPLC as dcacribcd in scc- 
tion 2 and wcrc detected simultaneously with UV-absorption at 447 
nm (la~cr panel), and fluorcsccncc dctcction (LSA, Pcrkin Elmer, 
Ucoconsficld. UK) at c!;citation 450 nm, cmihsion 520 em (II/I~CV 
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Fig. 3. NADPH consumption and uptake of molecular oxygen 
catalyzed by purified brain NO synthase in the absence of L-arginine 
and tetrahydrobiopterin. (A) NO synthase purified from porcine 
cerebellum (2 ag) was incubated at ambient temperature in 0.2 ml of 
a 50 mM triethanolaminc,‘XCl buffer, pH 7.0, containing 100 ,&I 
NADPH and 3rM free Ca” in the absence (filled circles) or presence 
(open circles) of 2 ,ug of calmodulin. The decrease in absorbance at 
340 nm was continuously monitored against blank samples containing 
buffer instead of enzyme. The data are representative for 4 similar ex- 
periments. (E) NO synthase (5Opg) was incubated in 2.5 ml as describ- 
ed for (A) in the absence (filled circles) or presence (open circles) of 
25 pg of calmodulin. Oxygen uptake was continuously monitored us- 
ing an oxygen-sensitive electrode (Braun, Melsungen. Germany) 
which had been calibrated in the presence of xanthine oxidase and 
defined amounts of xanthine. Data are representative for 3 similar cx- 
periments. 
nmol of L-citrulline. Thus, Hdbiopterin may be recycl- 
ed in an NADPH-dependent reaction like in other 
pteridine-dependent hydroxylating enzyme systems 
PA. 
The time-course of NADPH consumption catalyzed 
by purified NO synthase was studied as a decrease in ab- 
sorbance at 340 nm at ambient emperature. As shown 
in Fig. 3A, a calmodulin-dependent NADPH- 
consuming activity of approximately 150 nmol*mg-‘* 
min-’ was found. This NADPH consumption was not 
dependent on the presence of L-arginine or Hsbiopterin 
and was accompanied by a calmodulin-dependent up- 
take of molecular oxygen (Fig. 3B). Under these condi- 
tions, formation of hydrogen peroxide was observed, 
which was reduced in the presence of L-arginine and 
abolished when Hdbiopterin was additionally present 
(Heintel, B., John, M., Klatt, P., B6hme, E. and 
Mayer, B., unpublished). Thus, in the absence of L- 
arginine or Hdbiopterin, the Ca”/calmodulin-acti- 
vated enzyme appears to reduce molecular oxygen to 
hydrogen peroxide, similar to the plasma membrane- 
associated NADPH oxidase of neutrophils, which con- 
sists of various components including a flavoprotein 
1301. 
The results reported here favor a hypothetical reac- 
tion scheme for the biosynthesis of NO as shown in 
Fig. 4. As initial step, a Hdbiopterin-dependent N”- 
hydroxylation of L-arginine may result in the formation 
of N”-hydroxy_L-arginine, a compound which was 
189 








NADPH + H+ FAD 
‘4202 
Fig. 4. Hypothetical reaction mechanism of enzymatic NO formation from L-arginine. NADPH and 02 consumption. L-citrulline and NO forma- 
tion are reactions of NO synthase induced by Ca*‘/calmodulin. NO synthase contains FAD and FMN in equimolar amounts. According to the 
functions of FAD and FMN in cytochrome Paso reductase [36], FAD may transfer electrons from NADPH to FMN, and FMNHz may represent 
the final electron-donator. (Fe) indicates the possible involvement of non-heme iron according to a reaction scheme for Hd biopterin-dependent 
monooxygenases as postulated by Davies and Kaufman [28]. HOi may represent hydroperoxyl radical or an as yet unidentified reduced oxygen 
species. * hypothetical intermediate. (-I- ), alternative pathway used at suboptimal concentrations of L-arginine or Hdbiopterin. 
identified as an intermediate in NO formation by the 
macrophage nzyme [22]. This intermediate may react 
with an oxygen radical in a substituticn reaction, 
leading to the formation of NO and of a hypothetical 
hydrogen peroxide derivative of L-arginine, which may 
be cleaved into L-citrulline and water. In a flavin- 
coupled reaction, 2 oxygen radicals may be formed in 
one-electron transfer steps at the expense of one 
molecule of NADPH, explaining our finding that 1.5 
mol of NADPH are required for the formation of one 
mol of L-citrulline. 
NO synthase contains Hdbiopterin, FAD and FMN 
as coenzymes and represents a non-heme iron protein. 
The enzyme apparently acts as a multi-functional 
oxido-reductase exhibiting various enzymatic activities, 
including Hdbiopterin-dependent monooxygenase, 
NADPH-dependent dihydropteridine reductase and 
NADPH oxidase activity. These enzyme activities may 
simply provide the actual NO synthase with its 
substrates, i.e. with N”-hydroxy-L-arginine and oxygen 
radicals. This proposed reaction scheme provides an ex- 
planation for the results described here and for data ob- 
tained previously with the macrophage enzyme 
[21,22,27]. However, besides its function as electron- 
donator in the hydroxylation of L-arginine, Hdbiop- 
terin may have an additional protective ffect on NO 
synthase [22,27]. 
Our results may have important physiological im- 
plications, as toxic processes which have been at- 
tributed to oxygen radicals [31] may take place subse- 
quently to activation of NO synthase by Ca2+ at subop- 
timal levels of L-arginine or Hdbiopterln. The in- 
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tracellular concentrations of L-arginine are between 0.1 
and 2 mM [32] and do not appear to physiologically 
limit NO formation. Reduced levels of Hdbiopterin, 
however, were found in the brain and cerebrospinal 
fluid of patients affected with various neural diseases 
(for review see 1331). The key enzyme in the de novo 
synthesis of H4 biopterin, GTP cyclohydrolase I, was 
shown to be immunologically inducible [34], and inhibi- 
tion of this enzyme resulted in a reduced formation of 
NOZ-/NOJ- upon stimulation of murine fibroblasts by 
cytokines [35]. Low levels of intracellular Hdbiopterin 
may, therefore, limit NO formation and, according to 
our results, give rise to an NO synthase-catalyzed 
generation of oxygen radicals or hydrogen peroxide. 
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